CARE Ratings Limited (CARERATING:NSE) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the CARE Ratings Limited stock forecast from 0 analysts, the average analyst target price for CARE Ratings Limited is not available over the next 12 months. CARE Ratings Limited’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of CARE Ratings Limited is Neutral, which is based on 8 positive signals and 8 negative signals. At the last closing, CARE Ratings Limited’s stock price was INR 1,167.05. CARE Ratings Limited’s stock price has changed by +6.22% over the past week, +3.52% over the past month and +82.19% over the last year.
No recent analyst target price found for CARE Ratings Limited
No recent average analyst rating found for CARE Ratings Limited
Company Overview CARE Ratings Limited
CARE Ratings Limited, a credit rating agency, provides various rating and grading services in India, Mauritius, and Nepal. The company provides rating services for bank loan, debt instrument, bonds, non-convertible debentures, preference shares, fixed deposits, and commercial papers; principal protected market linked debentures, subordinate debt, perpetual bonds, and hybrid instruments; structured finance ratings; insurance ratings; infrastructure sector ratings; security receipts ratings; public finance rating services that cover ratings of state government entities and urban infrastructure projects; and real estate and infrastructure investment trusts ratings, as well as corporate governance ratings, project finance, and MLD valuation services. It also offers transaction and corporate advisory, project evaluation and monitoring, ESG assessment and advisory, research and analytics, industry research, and due diligence and grading services, as well as research and analytics to corporates, financial institutions, banks, and institutional investors. The company was formerly known as Credit Analysis and Research Limited and changed its name to CARE Ratings Limited in June 2017. CARE Ratings Limited was incorporated in 1993 and is headquartered in Mumbai, India. Address: Godrej Coliseum, Mumbai, India, 400022 Read Less
CARE Ratings Limited, a credit rating agency, provides various rating and grading services in India, Mauritius, and Nepal. The company provides rating services for bank loan, debt instrument, bonds, non-convertible debentures, preference shares, fixed deposits, and commercial pap...Read More
Frequently Asked Questions About CARE Ratings Limited (CARERATING:NSE) Stock
Stock Target Advisor's fundamental analysis for CARE Ratings Limited's stock is Neutral.
CARERATING:NSE stock's dividend yield is 1.24%.
Our analysis grades CARERATING:NSE stock's dividend yield at A+. This means that CARERATING:NSE stock's dividend yield is above 100% of the stocks in the Financial Data & Stock Exchanges sector in the NSE exchange.
Based on this CARERATING:NSE may be a good dividend stock for its sector.
Unfortunately we do not have enough data on CARERATING:NSE's stock to indicate what its average analyst target is.
CARERATING:NSE stock's Price/Earning ratio is 36.24.
Our analysis grades CARERATING:NSE stock's Price / Earning ratio at A+. This means that CARERATING:NSE stock's Price/Earning ratio is above 0% of the stocks in the Financial Data & Stock Exchanges sector in the NSE exchange.
Based on this CARERATING:NSE may be undervalued for its sector.
The last closing price of CARERATING:NSE's stock was INR 1,167.05.
The most recent market capitalization for CARERATING:NSE is INR 34.86B.
Unfortunately we do not have enough analyst data on CARERATING:NSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains CARE Ratings Limited's stock.
As per our most recent records CARE Ratings Limited has 517 Employees.
CARE Ratings Limited's registered address is Godrej Coliseum, Mumbai, India, 400022.
You can get more information about it from CARE Ratings Limited's website at https://www.careratings.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior total returns
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
Underpriced on free cash flow basis
The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
Superior Dividend Growth
This stock has shown top quartile dividend growth in the previous 5 years compared to its sector
What not to like
Poor capital utilization
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Poor return on equity
The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for CARERATING:NSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
